文献速递牙体牙髓病

口服甲泼尼龙对牙髓坏死伴症状性根尖周炎患者术后疼痛的随机双盲研究

Postoperative Pain Management with Oral Methylprednisolone in Symptomatic Patients with a Pulpal Diagnosis of Necrosis: A Prospective Randomized, Double-blind Study.
PubMed 文献 · J Endod · 2018-08-17

结果显示两组疼痛评分无统计学显著差异,提示该甲泼尼龙方案未能显著减轻术后疼痛。

要点

  • 牙髓坏死伴症状性根尖周炎患者清创后第1天40%-50%仍有中重度疼痛。
  • 口服甲泼尼龙方案与安慰剂相比未显著降低术后疼痛评分。
  • 所有患者均接受600 mg布洛芬及含阿片类补救药物。

核心结论

  • 与安慰剂相比,该口服甲泼尼龙方案未显著减轻牙髓坏死伴症状性根尖周炎患者完整清创后的术后疼痛。

主要发现

  • 第1天40%-50%患者经历中重度疼痛,第2天为31%,随后7天内疼痛评分下降。
  • 甲泼尼龙组与安慰剂组疼痛评分无统计学显著差异。

关键数值与推荐

  • 甲泼尼龙方案为治疗后立即口服96 mg,随后每日48 mg连续5天。
  • 所有患者均服用600 mg布洛芬,并按需使用含阿片类补救药物。

临床怎么用

  • 对于牙髓坏死伴症状性根尖周炎且术前中重度疼痛的急诊根管治疗患者,不应期待该口服甲泼尼龙方案显著减轻术后疼痛。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The purpose of this prospective randomized, double-blind, placebo-controlled study was to evaluate postoperative pain by using an oral dose regimen of methylprednisolone in symptomatic patients with pulpal necrosis and symptomatic apical periodontitis, a periapical radiolucency, and experiencing preoperative moderate to severe pain. METHODS: One hundred twenty-five adult symptomatic patients presenting for emergency endodontic treatment with a pulpal diagnosis of necrosis and symptomatic apical periodontitis, a periapical radiolucency, and experiencing moderate to severe pain participated. All patients received complete endodontic debridement and were randomly divided into 2 groups. In a double-blind manner, the groups received either an oral regimen of methylprednisolone (96 mg immediately after treatment followed by 48 mg each day for 5 consecutive days) or a lactose placebo. All patients received 600 mg ibuprofen and an opioid-containing escape medication to take if needed. Patients completed a 7-day diary to record pain and number of analgesic medications taken each day. RESULTS: Moderate to severe pain was experienced by 40%-50% of the patients on day 1 and 31% of the patients on day 2, with the pain ratings decreasing during the next 7 days. There were no statistically significant differences in pain ratings between the methylprednisolone and placebo groups. CONCLUSIONS: When compared with a placebo, the current regimen of oral methylprednisolone did not significantly reduce postoperative pain after complete debridement of symptomatic patients presenting for emergency endodontic treatment with a pulpal diagnosis of necrosis and symptomatic apical periodontitis, periapical radiolucency, and experiencing moderate to severe pain.

来源:J Endod,查看原文。版权归原作者所有。

引用

  1. Fuller M, Younkin K, Drum M, et al. Postoperative Pain Management with Oral Methylprednisolone in Symptomatic Patients with a Pulpal Diagnosis of Necrosis: A Prospective Randomized, Double-blind Study. J Endod. 2018. PMID: 30126618. doi:10.1016/j.joen.2018.06.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。